I had the pleasure of working with Steve for the past four years at Bayer. Steve's in-depth industry knowledge and experience coupled with a focus on delivering results is commendable. He collaboratively and diligently works developing short and long term multi-channel (trade and specialty) strategies integrating business insights and patient/customer perspectives into key decisions. I was impressed with his advanced business modeling and integration of work process flows to distill and simplify complex value propositions into integrated enterprise contracting strategies. We interacted frequently and he always shared the spotlight on collaborations when presented to leadership. He was and is a great mentor giving feedback and supporting areas for improvement. He is always a pleasure to be around with his thoughtful and engaging demeanor.

As US Brand Patient Marketing head, I led a time-sensitive & patient safety workstream to pivot our exclusively in-home Brand Patient Support Program, with the initial onset of Covid-19, towards a hybrid working model with both a remote & in-home exceptions option. The US Brand Team & I leaned heavy of Steve for his creativity, regulations insight & strategic commercial alignment to both patient & brand goals. While material program cost efficiencies were realized, this resulted without a loss in focus for patient-centric solutions. Thanks Steve for your valued contributions. 

Steve has been a true asset to the legal team in our assessment of various Market Access proposals. He has complete command over FMV assessments, but more importantly Steve has tremendous knowledge and experience in the Pharma access and distribution space. He explains scenarios in a digestible, understandable manner and comes to the discussion prepared to answer and offer solutions for anticipated compliance questions. An excellent collaboration partner and a colleague I can confidently recommend.

Stephen Lagano and I have worked together in both client and supplier settings. Stephen possesses a sharp analytical mind and real-time knowledge of the pharmaceutical industry. His background as a professional engineer provides Stephen with a competitive advantage especially in business process & supply chain optimization. He also is an expert in operational planning, trade and specialty channel management. He is especially knowledgeable about managed markets, channel and contracting strategies and analytics. 
Stephen is the ultimate team player, ensuring that all stakeholders are engaged in framing business issues, planning and implementation. He communicates ongoing progress through multiple touch points and prior to completing assessments, pressure tests the results to ensure that they are actionable. 
Most importantly, Stephen is always approachable and ready to provide guidance. His cross-functional expertise always yields well-reasoned advice, listens genuinely and has a passion for building both the business and the careers of those who work with and for him. 

I never pass up an opportunity to speak with Stephen or collaborate with him on business issues.

"I've had the great opportunity to work with Altometrixs and Steve on a number of projects at Vertex Pharmaceuticals. From helping us develop our Specialty Pharmacy channel strategy, to FMV analyses, to advanced analytics across specialty pharmacies, patients, wholesalers, payers, etc to helping us automate our sales reporting system. Steve always delivered top-notch results along with an attitude and energy you wished all your colleagues had. I wouldn't hesitate to recommend Altometrixs and Steve for any commercial and/or managed markets projects because I know that he will bring insights and experiences that enable tremendous results."

Although I knew and interacted with Steve in more than one of his roles while our time at Roche overlapped, the basis of this endorsement is the period during which Steve was in charge of the corporate business planning process. Processes of this type must reflect multiple dimensions: larger corporate objectives, for example, must eventually translate into brand and operational plans. It is the nitty-gritty of real work. Local market realities and functional limits necessarily constrain the larger objectives. A dynamic and productive balance must exist between the creative and analytical effort that goes into a process versus the actual results the business needs to achieve to satisfy its corporate HQ and, ultimately, its owners. It isn’t easy. 

During his time in charge of redesigning and implementing this process, Steve brought both comprehensive approaches as well as iterative refinements. He interacted with a variety of stakeholders. He jettisoned that which no longer pertained. He incorporated new thinking, assessing and presenting aggregated information. All of these attributes led to our ability on the executive team to optimize better our financial and workforce resources. Steve brought both a highly personable nature and a great deal of real world, in the trenches experience to the process. 

Most important, Steve led the process as a means to an end rather than as an end in itself. As such, he was able to garner a higher quality of participation throughout the organization. He took the organization from business planning to realize operational planning at all levels.